Four-peptide regenerative blend of BPC-157, GHK-Cu, TB-500, and KPV for recovery research models.
What it is
KLOW is a named four-peptide research blend of BPC-157, GHK-Cu, TB-500, and KPV. Composition adds the α-MSH-derived tripeptide KPV to the GLOW-class repair set for inflammation-signaling work alongside matrix and tissue-repair reagents.
The blend name is a catalog label for multi-peptide regenerative research—not a treatment claim. Left Turn Adventures supplies this blend for laboratory and research use only.
Also known as
KLOW blend · BPC-157 + GHK-Cu + TB-500 + KPV
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
Four-component repair, matrix, and inflammation endpoints
- Gut- and immune-adjacent KPV signaling plus BPC/TB/GHK readouts
- Dermal and soft-tissue remodeling markers in blend designs
- Anti-inflammatory literature endpoints across components
- Catalog convenience for four-peptide regenerative setups (not a protocol)
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early combined-component signaling in multi-peptide research setups; exposure establishing.
- Week 3–4: Clearer multi-pathway repair and matrix markers from the blend components in short windows.
- Month 2–3: More pronounced tissue and inflammation-related endpoints in extended designs.
- Month 3–6: Sustained multi-peptide research observations where longer protocols are used.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.